MIM Daroo Pharmaceutical Company

MIM Daroo Pharmaceutical Company was established in 2009 by the goal of creating a curative drug for migraine disease. After many years of rigorous research and large clinical trials at the only migraine clinic in the Middle East (Aramesh Multidisciplinary Pain Clinic of Tehran), MIM Daroo Pharmaceutical Company introduced the first curative medicine For migraine headaches in 2009. The original newly developed drug was in the form of inhalation and needed special processes to be used only at the clinics. The R&D team of MIM Daroo was then encouraged to develop a new version of migraine curative medicine. In 2016, MigraineCut , the first nasal spray to cure migraine passed all the requirements and was registered in Food and Drug Adminisration (FDA) of Iran and received its mass industrial production license.
MIMDaroo company now working in herbal and Nature based treatments for common annoying diseases such as Allergy, Eczema, Sinusitis and ... and the research and develpments team have achieved very promising results in treating these diseases.

Technical knowledge

MIMDaroo develops their products by the own technical knowledge and it constantly improved by the research and development team.

International pharmaceutical standards

MIMDaroo products are based on International pharmaceutical standards. 

Young and Motivated scientific team

The MIMDaroo Scientific team, consists of graduates and graduate students from the top universities of the Iran. 

Nature based Drugs

MIMDaroo products are based on Nature based drugs such as Herbal medicines.

News and Announcements

« »
Iran produces new herbal drug for headache

Iran produces new herbal drug for headache

TEHRAN – Iran has started the mass production of a new herbal drug – “Migraine Cut” – developed afte...

MigraineCut: Iranian curative medicine for migraine

The MIMDaroo company was developed the first migraine curative medicine in 2009, which name MigriHeal. it was based on aromatraphy and needed special processes to be used only at the clinics. The R&D team of MIMDaroo was encouraged to develop a new version of migraine curative medicine. In 2016, MigraineCut , the first spray to Cure Migraine passed all the requirements and was registered in Food and Drug Adminisration (FDA) of Iran and received mass industrial production license. The clinical trials were performed based on the International Headache Society (IHS) guidelines on 300 pa-tients. The curative efficacy of MigraineCut  has been 81% definite cure (as stated in the long-term follow-up surveys after the treatment) with nearly 96% mitigation. 

Form of usages

Liquid ethanol based Nasal Spray

Using Dosage:

Every 3 hourse or less based on your therapist advices.

Contact Us

Call us for more informaton 
+982196621411

جستجو